Replies to post #10250 on Lexington Biosciences Inc. (LXGTF)

[gopherdat]

From the past PR it was stated that the Heart Sentry exceeded expectations. The detailed numbers I think will be established in this next phase.
Also from a past article the CEO stated currant expectations/anticipations were to get FDA clearance by EOY and shooting for entering the commercial market by 1st qtr 2019. Go to their website to the NEWS section, it has all this info plus more and is very good reading.